Texas Children's Health Plan will be closed on Friday, July 4th, in observance of Independence Day. In our absence, you can reach our after-hours nurse help line at 1-800-686-3831. We will resume normal business hours on Monday, July 7th. Wishing you a safe and happy Independence Day!
El Plan de Salud Infantil de Texas estará cerrado el viernes 4 de julio por el Día de la Independencia. Durante nuestra ausencia, puede comunicarse con nuestra línea de ayuda disponible las 24 horas, los 7 días de la semana, al 1-800-686-3831. Reanudaremos nuestro horario habitual el lunes 7 de julio. ¡Le deseamos un feliz y seguro 4 de julio!
Cold and flu seasonTemporada de influenza y resfriados
ALERT:Stay healthy this cold and flu season!Learn more
ALERTA: ¡Mantente sano durante esta temporada de influenza y resfriados!Más información
Updated Prior Authorization Information for Benlysta (procedure code J0490) and Saphnelo (procedure code J0491)
Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers of prior authorization updates for Belimumab (Benlysta), procedure code J0490, and Anifrolumab-fnia (Saphnelo), procedure code J0491. Effective March 1, 2022, there is no prior authorization requirement for both, and age and diagnosis restrictions are indicated below.
Benlysta (J0490) is indicated to treat the following:
Active, autoantibody-positive, systemic lupus erythematosus (SLE) in clients who are 5 years of age or older, and receiving standard therapy
Adult clients with active Lupus Nephritis who are receiving standard therapy
Providers can now find information about procedure codes J0490 and J0491, in the current Texas Medicaid Provider Manual (TMPPM), Outpatient Drug Services Handbook, section 6.72, “Lupus Treatment Agents.”
Why is this important?
TCHP recognizes we may serve potentially impacted patients in our membership. We want to ensure that the member meets clinical evidence for treatment.
Next step for providers: Providers should refer to the Outpatient Drug Services Handbook chapter of the TMPPM for more details on the clinical policy and prior authorization requirements.